$RGEN
REPLIGEN CORP

2014 Q2 Form 10-Q Financial Statement

#000119312514304499 Filed on August 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2013 Q2
Revenue $15.55M $17.51M
YoY Change -11.18% 12.79%
Cost Of Revenue $6.671M $5.298M
YoY Change 25.92% -27.87%
Gross Profit $8.880M $12.21M
YoY Change -27.28% 49.3%
Gross Profit Margin 57.1% 69.74%
Selling, General & Admin $4.326M $3.124M
YoY Change 38.48% -8.6%
% of Gross Profit 48.72% 25.58%
Research & Development $1.430M $2.306M
YoY Change -37.99% -20.65%
% of Gross Profit 16.1% 18.88%
Depreciation & Amortization $970.0K $690.0K
YoY Change 40.58% -21.59%
% of Gross Profit 10.92% 5.65%
Operating Expenses $5.756M $5.430M
YoY Change 6.0% -14.14%
Operating Profit $3.106M $6.103M
YoY Change -49.11% 363.05%
Interest Expense $13.00K $12.40K
YoY Change 4.82% -54.67%
% of Operating Profit 0.42% 0.2%
Other Income/Expense, Net $65.00K -$122.0K
YoY Change -153.28% -126.64%
Pretax Income $3.243M $6.034M
YoY Change -46.25% 239.37%
Income Tax $418.0K $1.495M
% Of Pretax Income 12.89% 24.78%
Net Earnings $2.825M $4.539M
YoY Change -37.76% 189.11%
Net Earnings / Revenue 18.17% 25.92%
Basic Earnings Per Share $0.09 $0.14
Diluted Earnings Per Share $0.09 $0.14
COMMON SHARES
Basic Shares Outstanding 32.23M shares 31.64M shares
Diluted Shares Outstanding 33.08M shares 32.32M shares

Balance Sheet

Concept 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00M $58.10M
YoY Change -13.94% 104.58%
Cash & Equivalents $33.76M $37.33M
Short-Term Investments $16.30M $20.80M
Other Short-Term Assets $1.600M $2.000M
YoY Change -20.0% 81.82%
Inventory $12.82M $10.56M
Prepaid Expenses
Receivables $9.004M $4.871M
Other Receivables $400.0K $5.300M
Total Short-Term Assets $73.86M $80.91M
YoY Change -8.72% 54.54%
LONG-TERM ASSETS
Property, Plant & Equipment $12.55M $9.838M
YoY Change 27.57% -0.31%
Goodwill $13.35M $994.0K
YoY Change 1243.26% 0.0%
Intangibles $16.12M $6.499M
YoY Change 148.03% -9.44%
Long-Term Investments $11.90M $4.600M
YoY Change 158.7% -57.8%
Other Assets $500.0K $1.800M
YoY Change -72.22% 800.0%
Total Long-Term Assets $55.19M $23.74M
YoY Change 132.48% -18.39%
TOTAL ASSETS
Total Short-Term Assets $73.86M $80.91M
Total Long-Term Assets $55.19M $23.74M
Total Assets $129.0M $104.7M
YoY Change 23.31% 28.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.896M $1.481M
YoY Change 163.02% -42.7%
Accrued Expenses $4.920M $8.738M
YoY Change -43.7% 22.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.815M $10.22M
YoY Change -13.73% 4.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $4.663M $1.984M
YoY Change 135.07% -27.68%
Total Long-Term Liabilities $4.663M $1.984M
YoY Change 135.07% -27.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.815M $10.22M
Total Long-Term Liabilities $4.663M $1.984M
Total Liabilities $13.48M $12.20M
YoY Change 10.46% -2.19%
SHAREHOLDERS EQUITY
Retained Earnings -$81.95M -$98.27M
YoY Change -16.6% -15.65%
Common Stock $326.6K $318.1K
YoY Change 2.65% 3.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $115.6M $92.45M
YoY Change
Total Liabilities & Shareholders Equity $129.0M $104.7M
YoY Change 23.31% 28.49%

Cashflow Statement

Concept 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income $2.825M $4.539M
YoY Change -37.76% 189.11%
Depreciation, Depletion And Amortization $970.0K $690.0K
YoY Change 40.58% -21.59%
Cash From Operating Activities $2.320M $8.800M
YoY Change -73.64% 337.81%
INVESTING ACTIVITIES
Capital Expenditures -$620.0K -$790.0K
YoY Change -21.52% 125.71%
Acquisitions
YoY Change
Other Investing Activities -$17.19M $20.00K
YoY Change -86050.0% -98.85%
Cash From Investing Activities -$17.81M -$760.0K
YoY Change 2243.42% -155.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 840.0K 1.070M
YoY Change -21.5% 5250.0%
NET CHANGE
Cash From Operating Activities 2.320M 8.800M
Cash From Investing Activities -17.81M -760.0K
Cash From Financing Activities 840.0K 1.070M
Net Change In Cash -14.65M 9.110M
YoY Change -260.81% 167.16%
FREE CASH FLOW
Cash From Operating Activities $2.320M $8.800M
Capital Expenditures -$620.0K -$790.0K
Free Cash Flow $2.940M $9.590M
YoY Change -69.34% 306.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
32648098 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.53
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1795588 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37331578
CY2014Q1 us-gaap Security Deposit
SecurityDeposit
450000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32658782 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
419600 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.19
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1312741 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2818751 shares
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
791538 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
7.09
CY2014Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
22 Investment
CY2014Q2 us-gaap Share Price
SharePrice
22.79
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.05
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1211138 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32658782 shares
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1371000
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1371000
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1371000
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
8815401
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
404639
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2596382
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
13416575
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
660768
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
196784989
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3895722
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
655000
CY2014Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
183876
CY2014Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1371000
CY2014Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
2041833
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4662891
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
115561319
CY2014Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
7262
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81954897
CY2014Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
141481
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4919679
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
377177
CY2014Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2896541
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
326588
CY2014Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
0
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
129048493
CY2014Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
8882
CY2014Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
182000
CY2014Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
952733
CY2014Q2 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
11896949
CY2014Q2 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
60505
CY2014Q2 us-gaap Other Assets Fair Value Disclosure
OtherAssetsFairValueDisclosure
0
CY2014Q2 us-gaap Goodwill
Goodwill
14174045
CY2014Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
28162159
CY2014Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
16267093
CY2014Q2 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
376540
CY2014Q2 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
9212684
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
450000
CY2014Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
16119764
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9003874
CY2014Q2 us-gaap Inventory Net
InventoryNet
12823597
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1765000
CY2014Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4597137
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25966748
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1765000
CY2014Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
39527
CY2014Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
14173467
CY2014Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5175278
CY2014Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
8742000
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1765000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12550173
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1765000
CY2014Q2 us-gaap Assets
Assets
129048493
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
19013813
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33755718
CY2014Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2217096
CY2014Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7862172
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20475525
CY2014Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3051182
CY2014Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1765000
CY2014Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4328098
CY2014Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
302996
CY2014Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
28167466
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1587789
CY2014Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16270517
CY2014Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
19016305
CY2014Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
16270517
CY2014Q2 us-gaap Assets Current
AssetsCurrent
73857562
CY2014Q2 rgen Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
11896949
CY2014Q2 rgen Impact Of Credit Risk On Fair Value Of Derivatives
ImpactOfCreditRiskOnFairValueOfDerivatives
0
CY2014Q2 rgen Available For Sale Securities Debt Maturities One Through Two Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesOneThroughTwoYearsAmortizedCost
11895066
CY2014Q2 rgen Expected Effective Income Tax Rate For Current Fiscal Year
ExpectedEffectiveIncomeTaxRateForCurrentFiscalYear
0.2423 pure
CY2014Q2 rgen Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
3957
CY2014Q2 rgen Available For Sale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
9264
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29209821
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31925741 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.07
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1610988 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31925741 shares
CY2013Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
7591
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11301171
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1998330
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3166086
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12287010
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
599784
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
190625937
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1721459
CY2013Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
385478
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1648928
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3457631
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
103886102
CY2013Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1897473
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-89057422
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3341
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9579712
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10000
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1195248
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2404802
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
319257
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
118644904
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
183000
CY2013Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2324711
CY2013Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
12218602
CY2013Q4 us-gaap Goodwill
Goodwill
994000
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
34017451
CY2013Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
6730818
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
8973615
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
200000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
6187632
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4946132
CY2013Q4 us-gaap Inventory Net
InventoryNet
11798638
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2955120
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24796233
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
1984
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
13684954
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4557870
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12509223
CY2013Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
184848
CY2013Q4 us-gaap Assets
Assets
118644904
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39829653
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
2116017
CY2013Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4285648
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-3817118
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18088695
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
24947879
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
9655771
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1140496
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-93182
CY2013Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
21647
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
34012152
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1249824
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8592434
CY2013Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21793550
CY2013Q4 us-gaap Assets Current
AssetsCurrent
86350599
CY2013Q4 rgen Expected Effective Income Tax Rate For Current Fiscal Year
ExpectedEffectiveIncomeTaxRateForCurrentFiscalYear
0.2569 pure
CY2013Q4 rgen Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
9936
CY2013Q4 rgen Available For Sale Debt Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleDebtSecuritiesGrossUnrealizedGainAccumulatedInInvestments
4637
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32115519 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
12390684
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
672255 shares
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.20
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.84
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
540552 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31443264 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1105217
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
762000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6621
us-gaap Income Taxes Paid
IncomeTaxesPaid
771000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
695795
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
814837
us-gaap Investment Income Net
InvestmentIncomeNet
127124
us-gaap Revenues
Revenues
33964960
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
334937
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5730306
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
18587
us-gaap Operating Income Loss
OperatingIncomeLoss
9647762
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
6373000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
37343000
us-gaap Royalty Revenue
RoyaltyRevenue
9017081
us-gaap Net Income Loss
NetIncomeLoss
6877423
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-360872
us-gaap Cost Of Goods Sold
CostOfGoodsSold
12194417
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2034545
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
992856
us-gaap Costs And Expenses
CostsAndExpenses
24317198
us-gaap Share Based Compensation
ShareBasedCompensation
562762
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1508943
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
8121757
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5810909
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13383003
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1219593
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6432039
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2778348
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-492563
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
592030
us-gaap Interest Expense
InterestExpense
25933
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-958014
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-194945
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2034545
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
562762
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4489736
rgen Change In Fair Value Of Acquisition Related Contingent Consideration
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
-18587
dei Trading Symbol
TradingSymbol
RGEN
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><b>1.</b></td> <td align="left" valign="top"><b>Basis of Presentation</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The consolidated financial statements included herein have been prepared by Repligen Corporation (the &#x201C;Company,&#x201D; &#x201C;Repligen&#x201D; or &#x201C;we&#x201D;) in accordance with generally accepted accounting principles in the United States (&#x201C;U.S. GAAP&#x201D;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201C;SEC&#x201D;), for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#xA0;31, 2013.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M17D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
339698 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32963554 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.37
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
10320326
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
865285 shares
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.25
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.178 pure
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
10.85
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y6M22D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
573238 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
6.92
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
103124
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300908 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.36
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M28D
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32098269 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
64707 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M10D
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1224091
us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12066
us-gaap Income Taxes Paid
IncomeTaxesPaid
668000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
646322
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-6354278
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18635241
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21235937
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
29885764
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
67785
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1593691
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8641354
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1605757
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2547815
us-gaap Investment Income Net
InvestmentIncomeNet
186736
us-gaap Revenues
Revenues
31876930
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
300432
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
1400000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5508834
us-gaap Gain Loss On Investments
GainLossOnInvestments
0
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-116020
us-gaap Operating Income Loss
OperatingIncomeLoss
8413698
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7996000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
35659000
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2640
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
250000
us-gaap Royalty Revenue
RoyaltyRevenue
1991166
us-gaap Net Income Loss
NetIncomeLoss
7102525
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
286261
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
-1593691
us-gaap Cost Of Goods Sold
CostOfGoodsSold
13006645
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1337906
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
153704
us-gaap Costs And Expenses
CostsAndExpenses
23463232
us-gaap Share Based Compensation
ShareBasedCompensation
852637
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1855392
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6073935
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16853276
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24491993
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7709444
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1538829
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-878891
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4844919
us-gaap Interest Expense
InterestExpense
26865
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
673461 shares
CY2013Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.14
CY2013Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.14
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
520552 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31643695 shares
CY2013Q2 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
142000
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4638
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2069947
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-207390
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1337906
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
570000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
852637
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
1110219
us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
2115000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2631123
rgen Nonrefundable Upfront Cash Payment Under Collaborations Agreement
NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement
2000000
rgen Long Term Marketable Securities Maturities Term Minimum
LongTermMarketableSecuritiesMaturitiesTermMinimum
P1Y
rgen Royalty Payment Rate
RoyaltyPaymentRate
0.15 pure
rgen Payment To Be Received Upon Signing Of Agreement
PaymentToBeReceivedUponSigningOfAgreement
126375
rgen Marketable Securities Remaining Maturity
MarketableSecuritiesRemainingMaturity
P10M9D
rgen Change In Fair Value Of Acquisition Related Contingent Consideration
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
116020
CY2014Q1 us-gaap Lessee Leasing Arrangements Operating Leases Term Of Contract
LesseeLeasingArrangementsOperatingLeasesTermOfContract
P8Y1M
CY2014Q1 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
361000
CY2014Q1 rgen Lease Agreement Area
LeaseAgreementArea
75594 sqft
CY2013 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P8Y
CY2013 us-gaap Gain Loss On Investments
GainLossOnInvestments
0
CY2013Q1 us-gaap Income Tax Expense Benefit Extraordinary Items
IncomeTaxExpenseBenefitExtraordinaryItems
298000
CY2014Q1 rgen Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance
NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance
2000000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32317156 shares
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
13013610
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-122263
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
6033703
CY2014Q2 us-gaap Revenues
Revenues
15551077
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-883888
CY2013Q2 us-gaap Investment Income Net
InvestmentIncomeNet
65605
CY2013Q2 us-gaap Revenues
Revenues
17508967
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3650661
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6102763
CY2013Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4394000
CY2013Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
19047000
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
4495357
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
4539187
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5297809
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
11406204
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
312691
CY2013Q2 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
642736
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3123940
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1494516
CY2013Q2 us-gaap Interest Expense
InterestExpense
12402
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
312691
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2306332
CY2013Q2 rgen Change In Fair Value Of Acquisition Related Contingent Consideration
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
35387
CY2014Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
CY2014Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
CY2014Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33076384 shares
CY2014Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
842690 shares
CY2014Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.12
CY2014Q2 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.12
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
264317 shares
CY2014Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32233694 shares
CY2014Q2 us-gaap Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
0
CY2014Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9882
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
15551077
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
65280
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3243249
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1462603
CY2014Q2 us-gaap Investment Income Net
InvestmentIncomeNet
84920
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1372701
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3105829
CY2014Q2 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
3818000
CY2014Q2 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
17707000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
2825422
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
6671581
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
12445248
CY2014Q2 us-gaap Share Based Compensation
ShareBasedCompensation
545212
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4325834
CY2014Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
417827
CY2014Q2 us-gaap Interest Expense
InterestExpense
12780
CY2014Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
545212
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1430133
CY2014Q2 rgen Change In Fair Value Of Acquisition Related Contingent Consideration
ChangeInFairValueOfAcquisitionRelatedContingentConsideration
17700
CY2012Q4 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
3021000

Files In Submission

Name View Source Status
0001193125-14-304499-index-headers.html Edgar Link pending
0001193125-14-304499-index.html Edgar Link pending
0001193125-14-304499.txt Edgar Link pending
0001193125-14-304499-xbrl.zip Edgar Link pending
d758443d10q.htm Edgar Link pending
d758443dex103.htm Edgar Link pending
d758443dex311.htm Edgar Link pending
d758443dex312.htm Edgar Link pending
d758443dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20140630.xml Edgar Link completed
rgen-20140630.xsd Edgar Link pending
rgen-20140630_cal.xml Edgar Link unprocessable
rgen-20140630_def.xml Edgar Link unprocessable
rgen-20140630_lab.xml Edgar Link unprocessable
rgen-20140630_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending